Showing results (191-200 of 298) with videos related to
Sort By:
Pageof 30
Parasites & Vectors|August 10, 2023
Exploring the landscape of Babesia bovis vaccines: progress, challenges, and opportunitiesJohn Harvey M Santos, Hannah V Siddle, Ali Raza, et al.Drug Development and Industrial Pharmacy|November 9, 2018
Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targetingShadab Md, Jasvinder Kaur A/P Kuldeep Singh, Muhammad Waqas, et al.Journal of Autoimmunity|May 20, 2003
Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M proteinRobyn S Lymbury, Colleen Olive, Kellie A Powell, et al.Proceedings of the National Academy of Sciences of the United States of America|February 21, 2003
The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malariaMorris O Makobongo, George Riding, Huji Xu, et al.Materials Science & Engineering. C, Materials for Biological Applications|July 24, 2018
An overview of application of silver nanoparticles for biomaterials in dentistryRanjeet A Bapat, Tanay V Chaubal, Chaitanya P Joshi, et al.Pharmaceutics|December 16, 2020
Novel Approaches for the Treatment of Pulmonary TuberculosisZhi Ming Tan, Gui Ping Lai, Manisha Pandey, et al.The Journal of Experimental Medicine|April 3, 2002
The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infectionHuji Xu, Jiraprapa Wipasa, Huaru Yan, et al.The Journal of Infectious Diseases|May 2, 2003
Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protectionMichael R Batzloff, Wendy A Hayman, Mark R Davies, et al.Artificial Cells, Nanomedicine, and Biotechnology|June 7, 2018
Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacyZahid Hussain, Mahwish Arooj, Arif Malik, et al.Gels (Basel, Switzerland)|November 29, 2021
Site-Specific Vesicular Drug Delivery System for Skin Cancer: A Novel Approach for TargetingManisha Pandey, Hira Choudhury, Bapi Gorain, et al.Pageof 30